{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T02:36:04Z","timestamp":1793414164814,"version":"4.5.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,21]],"date-time":"2021-01-21T00:00:00Z","timestamp":1611187200000},"content-version":"vor","delay-in-days":386,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000850","name":"National Heart and Lung Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000850","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000850","name":"National Heart and Lung Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000850","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.jacc.2019.10.058","type":"journal-article","created":{"date-parts":[[2020,1,13]],"date-time":"2020-01-13T16:42:12Z","timestamp":1578933732000},"page":"148-158","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":81,"title":["Incident Heart\u00a0Failure and Long-Term Risk for Venous Thromboembolism"],"prefix":"10.1016","volume":"75","author":[{"given":"Christina L.","family":"Fanola","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faye L.","family":"Norby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amil M.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia P.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela L.","family":"Lutsey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wayne D.","family":"Rosamond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Cushman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron R.","family":"Folsom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2019.10.058_bib1","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1161\/CIR.0000000000000558","article-title":"Heart disease and stroke statistics 2018 update","volume":"137","author":"Benjamin","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2019.10.058_bib2","first-page":"1424","article-title":"Does heart failure confer a hypercoagulable state? Virchow\u2019s triad revisited","volume":"33","author":"Lip","year":"1999","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2019.10.058_bib3","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.amjmed.2008.05.045","article-title":"Epidemiology of venous thromboembolism in cardiorespiratory and infectious disease","volume":"121","author":"Alikhan","year":"2008","journal-title":"Am J Med"},{"key":"10.1016\/j.jacc.2019.10.058_bib4","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1001\/archinte.164.9.963","article-title":"Risk factors for venous thromboembolism in hospitalized patients with acute medical illness: analysis of the MEDENOX study","volume":"164","author":"Alikhan","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacc.2019.10.058_bib5","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.amjmed.2015.10.014","article-title":"Lifetime risk of venous thromboembolism in two cohort studies","volume":"129","author":"Bell","year":"2016","journal-title":"Am J Med"},{"key":"10.1016\/j.jacc.2019.10.058_bib6","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.amjmed.2004.01.018","article-title":"Deep vein thrombosis and pulmonary embolism in two cohorts: the longitudinal investigation of thromboembolism etiology","volume":"1","author":"Cushman","year":"2004","journal-title":"Am J Med"},{"key":"10.1016\/j.jacc.2019.10.058_bib7","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1136\/bmj.38733.466748.7C","article-title":"Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial","volume":"332","author":"Cohen","year":"2006","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2019.10.058_bib8","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1177\/1358863X07079017","article-title":"Thromboprophylaxis with dalteparin in medical patients: which patients benefit?","volume":"12","author":"Cohen","year":"2007","journal-title":"Vasc Med"},{"key":"10.1016\/j.jacc.2019.10.058_bib9","doi-asserted-by":"crossref","first-page":"e195S","DOI":"10.1378\/chest.11-2296","article-title":"Prevention of VTE in nonsurgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"141","author":"Kahn","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.jacc.2019.10.058_bib10","doi-asserted-by":"crossref","first-page":"3198","DOI":"10.1182\/bloodadvances.2018022954","article-title":"American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients","volume":"22","author":"Sch\u00fcnemann","year":"2018","journal-title":"Blood Adv"},{"key":"10.1016\/j.jacc.2019.10.058_bib11","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1016\/S2352-3026(15)00228-8","article-title":"Heart failure and risk of venous thromboembolism: a systematic review and meta-analysis","volume":"1","author":"Tang","year":"2016","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.jacc.2019.10.058_bib12","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1177\/1358863X14520869","article-title":"Troponin T, NT-pro BNP, and venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology (LITE)","volume":"19","author":"Folsom","year":"2014","journal-title":"Vasc Med"},{"key":"10.1016\/j.jacc.2019.10.058_bib13","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1001\/archinte.162.10.1182","article-title":"Cardiovascular risk factors and venous thromboembolism incidence: the longitudinal investigation of thromboembolism etiology","volume":"162","author":"Tsai","year":"2002","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacc.2019.10.058_bib14","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1093\/oxfordjournals.aje.a115184","article-title":"The Atherosclerosis Risk in Communities (ARIC) study: design and objectives","volume":"129","year":"1989","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jacc.2019.10.058_bib15","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1093\/oxfordjournals.eurheartj.a062365","article-title":"Cardiac and pulmonary causes of dyspnoea- validation of a scoring test for clinical-epidemiological use: the Study of Men Born in 1913","volume":"8","author":"Eriksson","year":"1987","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2019.10.058_bib16","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.amjcard.2007.11.061","article-title":"Heart failure incidence and survival (from the Atherosclerosis Risk in Communities study)","volume":"101","author":"Loehr","year":"2008","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2019.10.058_bib17","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1161\/CIRCHEARTFAILURE.111.963199","article-title":"Classification of heart failure in the Atherosclerosis Risk in Communities (ARIC) study: a comparison of diagnostic criteria","volume":"5","author":"Rosamond","year":"2012","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jacc.2019.10.058_bib18","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1161\/CIRCIMAGING.113.000736","article-title":"Rationale and design of a multicenter echocardiographic study to assess the relationship between cardiac structure and function and heart failure risk in a biracial cohort of community-dwelling elderly persons: the Atherosclerosis Risk in Communities study","volume":"1","author":"Shah","year":"2014","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.jacc.2019.10.058_bib19","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1378\/chest.06-2993","article-title":"Venous thromboembolism prophylaxis in acutely ill hospitalized medical patients","volume":"132","author":"Tapson","year":"2007","journal-title":"Chest"},{"key":"10.1016\/j.jacc.2019.10.058_bib20","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1378\/chest.06-2077","article-title":"Acute pulmonary embolism is an independent predictor of adverse events in severe decompensated heart failure patients","volume":"131","author":"Darze","year":"2007","journal-title":"Chest"},{"key":"10.1016\/j.jacc.2019.10.058_bib21","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1056\/NEJM199909093411103","article-title":"A\u00a0comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients","volume":"341","author":"Samama","year":"1999","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2019.10.058_bib22","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1056\/NEJMoa1601747","article-title":"Extended thromboprophylaxis with betrixaban in acutely ill medical patients","volume":"375","author":"Cohen","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2019.10.058_bib23","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ahj.2004.03.010","article-title":"The Warfarin\/Aspirin Study in Heart\u00a0Failure (WASH): a randomized trial comparing antithrombotic strategies for patients with heart failure","volume":"148","author":"Cleland","year":"2004","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2019.10.058_bib24","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.ejheart.2006.02.012","article-title":"Efficacy of antithrombotic therapy in chronic heart failure: the HELAS study","volume":"8","author":"Cokkinos","year":"2006","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2019.10.058_bib25","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1161\/CIRCULATIONAHA.108.801753","article-title":"Randomized trial of warfarin, aspirin, and clopidogrel in patients with chronic heart failure: the Warfarin and Antiplatelet Therapy in Chronic Heart\u00a0Failure (WATCH) trial","volume":"119","author":"Massie","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2019.10.058_bib26","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1056\/NEJMoa1202299","article-title":"Warfarin and aspirin in patients with heart failure and sinus rhythm","volume":"366","author":"Homma","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2019.10.058_bib27","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1056\/NEJMoa1808848","article-title":"Rivaroxaban in patients with heart failure, sinus rhythm and coronary artery disease","volume":"379","author":"Zannad","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2019.10.058_bib28","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0167-5273(95)02327-S","article-title":"Is diastolic dysfunction associated with thrombogenesis? A study of circulating markers of a prothrombotic state in patients with coronary artery disease","volume":"50","author":"Lip","year":"1995","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2019.10.058_bib29","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.echo.2016.01.014","article-title":"Impact of diastolic function parameters on the risk for left atrial appendage thrombus in patients with nonvalvular atrial fibrillation: a prospective study","volume":"29","author":"Doukky","year":"2016","journal-title":"J\u00a0Am Soc Echocardiogr"},{"key":"10.1016\/j.jacc.2019.10.058_bib30","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1161\/CIRCULATIONAHA.105.600437","article-title":"Stage B heart failure: management of asymptomatic left ventricular systolic dysfunction","volume":"113","author":"Goldberg","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2019.10.058_bib31","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1001\/jamainternmed.2015.0936","article-title":"Outcomes in adults with acute pulmonary embolism who are discharged from emergency departments: the Cardiovascular Research Network Venous Thromboembolism study","volume":"175","author":"Fang","year":"2015","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jacc.2019.10.058_bib32","doi-asserted-by":"crossref","first-page":"e137","DOI":"10.1097\/MLR.0000000000000524","article-title":"Validity of using inpatient and outpatient administrative codes to identify acute venous thromboembolism: the CVRN VTE study","volume":"55","author":"Fang","year":"2017","journal-title":"Med Care"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109719384669?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109719384669?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T13:28:38Z","timestamp":1760016518000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109719384669"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S0735109719384669"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2019.10.058","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incident Heart\u00a0Failure and Long-Term Risk for Venous Thromboembolism","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2019.10.058","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}